These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2416805)

  • 21. Cytotoxic T lymphocyte responses to minor H-43 alloantigens in H-43a and H-43b mice. Both anti-H-43b and anti-H-43a CTL activities are generated exclusively in the context of the same H-2Kb restriction element.
    Ishikawa H; Kusakabe A; Hayakawa J; Hino T
    J Immunol; 1988 Nov; 141(9):2918-23. PubMed ID: 3139769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH; Miller RG
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal analysis of H-2Kb + TNP recognition by T cells with the use of H-2Kbm mutants and H-2Kb-specific monoclonal antibodies.
    Davignon JL; Guimezanes A; Schmitt-Verhulst AM
    J Immunol; 1983 Sep; 131(3):1073-9. PubMed ID: 6193173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b.
    DeCloux A; Woods AS; Cotter RJ; Soloski MJ; Forman J
    J Immunol; 1997 Mar; 158(5):2183-91. PubMed ID: 9036964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degeneracy of H-2 recognition by cytotoxic T lymphocytes: 10% of the total repertoire is "specific" for a given haplotype and up to 1% is self-H-2 reactive.
    Beretta A; Ermonval M; Larsson EL
    Eur J Immunol; 1986 Jun; 16(6):605-9. PubMed ID: 2424765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens.
    Cassell DJ; Forman J
    J Immunol; 1990 Jun; 144(11):4075-81. PubMed ID: 2140385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of the alloreactive T cell repertoire: K region homology between H-2b T cell precursors and T cell maturation environment is required for the generation of the Kbm6-specific cytotoxic T cell repertoire.
    Gress RE; Hodes RJ
    J Immunol; 1984 May; 132(5):2226-31. PubMed ID: 6201535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-2 unrestricted cytotoxic T cell activity against antigens controlled by genes in the QA/TLA region.
    Forman J
    J Immunol; 1979 Dec; 123(6):2451-5. PubMed ID: 387870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Qa-1/Tla region alloantigen-specific CTL with alpha beta receptor.
    Germana S; Shinohara N
    Immunology; 1991 Dec; 74(4):578-82. PubMed ID: 1838350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qc-1, a novel Q-region-controlled CTL determinant expressed on B lymphocytes.
    Homer RJ; Murphy DB
    J Immunol; 1987 Jun; 138(12):4322-8. PubMed ID: 2438340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Qa-1 alloantigens. III. Biochemical analysis of the structure and extent of polymorphism of the Qa-1 allelic products.
    Landolfi NF; Rich RR; Cook RG
    J Immunol; 1985 Aug; 135(2):1264-70. PubMed ID: 3925004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants.
    Webb SR; Okamoto A; Sprent J
    J Immunol; 1988 Sep; 141(6):1828-34. PubMed ID: 2459192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T lymphocyte recognition of novel allodeterminants expressed on in vitro selected H-2Kb mutants.
    Lewis J; Foo M; Geier SS; Kumar PA; Nathenson SG; Bluestone JA
    J Immunol; 1988 Aug; 141(3):728-35. PubMed ID: 2456331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.